Literature DB >> 15793852

A biphasic response of hepatobiliary cholesterol metabolism to dietary fat at the onset of obesity in the mouse.

Suheeta Roy1, Hideyuki Hyogo, Suresh K Yadav, Michele K Wu, Linda A Jelicks, Joseph D Locker, Philippe G Frank, Michael P Lisanti, David L Silver, David E Cohen.   

Abstract

Human obesity is associated with abnormal hepatic cholesterol homeostasis and resistance to leptin action. Because leptin administration to rodents promotes the biliary elimination of plasma cholesterol, this study was designed to elucidate a pathophysiological role for leptin during the development of obesity. We fed mice diets containing high or low saturated fat contents. Before and after the onset of obesity, we measured downstream targets of leptin action and evaluated plasma, hepatic, and biliary cholesterol metabolism. Although not obese at 28 days, mice fed a high fat diet became hyperleptinemic. Sensitivity to leptin was evidenced by downregulation of both hepatic stearoyl CoA desaturase-1 and fatty acid synthase. Due principally to upregulation of adenosine triphosphate-binding cassette proteins A1 and G5, plasma high density lipoprotein (HDL) cholesterol concentrations increased, as did relative secretion rates of biliary cholesterol. A smaller, more hydrophilic bile salt pool decreased intestinal cholesterol absorption. In this setting, hepatic cholesterol synthesis was downregulated, indicative of increased uptake of plasma cholesterol. After 56 days of high fat feeding, obesity was associated with leptin resistance, as evidenced by marked hyperleptinemia without downregulation of stearoyl CoA desaturase-1 or fatty acid synthase and by upregulation of hepatic cholesterol and bile salt synthesis. Hypercholesterolemia was attributable to overproduction and decreased clearance of large HDL(1) particles. In conclusion, before the onset of obesity, preserved leptin sensitivity promotes biliary elimination of endogenous cholesterol in response to dietary fat. Leptin resistance due to obesity leads to a maladaptive response whereby newly synthesized cholesterol in the liver is eliminated via bile.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15793852     DOI: 10.1002/hep.20643

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  5 in total

1.  Acceleration of biliary cholesterol secretion restores glycemic control and alleviates hypertriglyceridemia in obese db/db mice.

Authors:  Kai Su; Nadezhda S Sabeva; Yuhuan Wang; Xiaoxi Liu; Joshua D Lester; Jingjing Liu; Shuang Liang; Gregory A Graf
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-11-07       Impact factor: 8.311

2.  Targeted deletion of thioesterase superfamily member 1 promotes energy expenditure and protects against obesity and insulin resistance.

Authors:  Yongzhao Zhang; Yingxia Li; Michele W Niepel; Yuki Kawano; Shuxin Han; Sihao Liu; Alessandro Marsili; P Reed Larsen; Chih-Hao Lee; David E Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-16       Impact factor: 11.205

3.  Hepatic nuclear corepressor 1 regulates cholesterol absorption through a TRβ1-governed pathway.

Authors:  Inna Astapova; Preeti Ramadoss; Ricardo H Costa-e-Sousa; Felix Ye; Kaila A Holtz; Yingxia Li; Michele W Niepel; David E Cohen; Anthony N Hollenberg
Journal:  J Clin Invest       Date:  2014-04-08       Impact factor: 14.808

Review 4.  Hepatic high-density lipoprotein receptors: roles in lipoprotein metabolism and potential for therapeutic modulation.

Authors:  Bernardo L Trigatti
Journal:  Curr Atheroscler Rep       Date:  2005-09       Impact factor: 5.113

5.  Integrating human omics data to prioritize candidate genes.

Authors:  Yong Chen; Xuebing Wu; Rui Jiang
Journal:  BMC Med Genomics       Date:  2013-12-18       Impact factor: 3.063

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.